ADMA vs CPRT · P/E 22, rev $238.9M vs P/E 19, rev $3.51B
ADMA Biologics Inc (ADMA) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Copart Inc (CPRT) is a specialty business services company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the ADMA and CPRT stock pages for the full models.
Not investment advice.